Our Team
Mary Fox | Founding Partner
Mary prides herself on a business-minded approach to protecting her clients’ intellectual property, specifically tailoring the patent strategy to the client’s competitive objectives. Mary has extensive experience working with emerging companies at all stages of growth. In the past two years, she was involved in raising over $100 million in venture funding for emerging medical device companies. Mary also has extensive experience in portfolio development and patent strategies, post-grant procedures, freedom to operate analyses and other intellectual property due diligence.
Mary focuses her practice on the medical device industry, including patent prosecution, strategic portfolio development, investor-side and company-side patent due diligence, and freedom to operate analyses. Mary has particular expertise in neurovascular devices, interventional cardiovascular devices, transcatheter heart valve repair and replacement, drug delivery, neurostimulation, neuromodulation, orthodontics, spinal stimulation, microfluidics, wound care and monitoring, and orthopedics. She also has experience in a variety of other technologies, including audio devices, acoustic signal processing, semiconductor fabrication and design, genomics, stereo imaging, and consumer products.
Before co-founding Fortem IP, Mary worked as a patent attorney at Perkins Coie in Seattle and Palo Alto. Prior to her legal career, Mary worked in the Bay Area at The Foundry, Ardian, and Miramar Labs.
Mary was selected as a “Washington Rising Star” for 2018-2023 by Super Lawyers Magazine.
EDUCATION
BS Biomedical Engineering, University of Michigan
MS Biomedical Engineering, University of Michigan
JD, Santa Clara University School of Law
BAR ADMISSIONS
California
Washington
United States Patent and Trademark Office
PUBLICATIONS
Co-author, IP Strategies for Medical Device Technologies, American Bar Association 2018, Chapter 3 “Funding: Leveraging Your Patent Portfolio,” 115-132.
Co-author, Traversing Material Scales: Macroscale LBL-Assembled Nanocomposites with Microscale Inverted Colloidal Crystal Architecture, Chem. Mater. 2012, 24, 9-11.